Progress of Impairment Scores Following Commencement of Chemotherapy in Multibacillary Leprosy Patients

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 65, Issue 3, 1997, Pages 328-336

  Reed, Naomi K ^a   Van Brakel, Wim H ^b   Reed, Darren S ^c  

^a Green Pastures Hospital and Rehabilitation Centre Nepal   (Nepal)

^b International Nepal Fellowship   (Nepal)

^c Western Regional Hospital   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; SCORING SYSTEM; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; COHORT STUDIES; DISABLED PERSONS; FEMALE; HUMANS; LEPROSY; MALE; NEPAL; RETROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS;

EID: 0030723161     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BECHELLI, L. M. and DOMINGUEZ, V. M. Disability index for leprosy patients. Bull. WHO 44 (1971) 709-713.
2. BRANDSMA, J. W., HEERKENS, Y. F., LAKERVELD-HEYL, K. and MISCHNER-VAN RAVENSBERO, C. D. The international classification of impairments, disabilities and handicaps in leprosy control projects. Lepr. Rev, 63 (1992) 337-344.
3. CLAYTON, D. and HILLS, M. Statistical Models in Epidemiology. Oxford: Oxford University Press, 1993.
4. DE RIJK, A. J., GABRE, S., BYASS, P. and BERHANU, T. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project - I. MDT course completion, case holding and another score for disability grading. Lepr. Rev. 65 (1994) 305-319.
5. GIRDHAR, K., ARORA, S. K., HOHAN, L. and MUKHIJA, R. D. Pattern of leprosy disabilities in Gorakhpur (Uttar Pradesh). Indian J. Lepr. 61 (1989) 503-513.
6. GUPTE, M. D. Dapsone treatment and deformities: a retrospective study. Lepr. India 51 (1979) 218-233.
7. HASAN, S. A survey of leprosy deformities among the patients of Hyderabad city. Lepr. India 49 (1977) 393-399.
8. KAUR, P. and SINGH, G. Deformities in leprosy patients attending urban leprosy clinic at Varanasi. Indian J. Lepr. 57 (1985) 178-182.
9. KEELER, R. F. and RYAN, M. A. The incidence of disabilities in Hansen's disease after the commencement of chemotherapy. Lepr. Rev. 51 (1980) 149-154.
10. KUSHWAH, S. S., GOVILA, A. K. and KUSHWAH, J. An epidemiological study of disabilities among leprosy patients attending leprosy clinic in Gwalior. Lepr. India 53 (1981) 240-247.
11. MISHRA, B., RAMU, G., CHAUHAN, V. S., KUSHWAH, S. S. and DWIVEDI, M. P. Leprosy deformities. II. As parameters to monitor the effectivity of leprosy control programme. Indian J. Lepr. 60 (1988) 260-266.
12. PONNIGHAUS, I. M., BOERRIGTER, G., FINE, P, E. M., PONNIGHAUS, J. M. and RUSSELL, J. Disabilities in leprosy patients ascertained in a total population survey in Karonga district, northern Malawi. Lepr. Rev. 61 (1990) 366-374.
13. PONNIGHAUS, J. M. and BOERRIGTER, G. Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi. Int. J. Lepr. 63 (1995) 1-7.
14. RADHAKRISHNA, S. and NAIR, G. K. Association between regularity in dapsone (DDS) treatment and development of deformity. Int. J. Lepr. 55 (1987) 425-434.
15. SCHIPPER, A., LUBBERS, W. J., HOGEWEG, M. and DE SOLDENHOFF, R. Disabilities of hands, feet and eyes in newly diagnosed leprosy patients in eastern Nepal. Lepr. Rev. 65 (1994) 239-247.
16. SMITH, W. C. S. The epidemiology of disability in leprosy including risk factors. Lepr. Rev. 63 Suppl. (1992) 23s-30s.
17. SMITH, W. C. S. and PARKHE, S. M. Disability assessment as a measure of progress in leprosy control. Lepr. Rev. 57 (1986) 251-259.
18. SMITH, W. C. S., ANTIN, U. S. and PATOLE, A. R. Disability in leprosy: a relevant measurement of progress in leprosy. Lepr. Rev. 51 (1980) 155-166.
19. SRINIVASAN, H. and NOORDEEN, S. K. Epidemiology of disability in leprosy. 2. Factors associated with low disability. Int. J. Lepr. 34 (1965) 170-174
20. VAN BRAKEL, W. H., DE SOLDENHOFF, R. and MCDOUGALL, A. C. The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions. Lepr. Rev. 63 (1992) 231-245.
21. VAN BRAKEL, W. H. and KHAWAS, I. B. Nerve damage in leprosy: an epidemiological study of 396 patients in West Nepal - part 1: definitions, methods and frequencies. Lepr. Rev. 65 (1994) 204-221.
22. VAN GIJN, J. Measurement of outcome in stroke prevention trials. Cerebrovasc. Dis. 2 Suppl. 1 (1992) 23-34.
23. WHO EXPERT COMMITTEE ON LEPROSY. Fourth report. Geneva: World Health Organization, 1970. WHO Tech. Rep. Ser. 459.
24. WHO EXPERT COMMITTEE ON LEPROSY. Sixth report. Geneva: World Health Organization, 1988. WHO Tech Rep. Ser. 768.
25. WORLD HEALTH ORGANIZATION. International classification of impairments, disabilities and handicaps. Geneva: World Health Organization, 1980.